ContraFect Announces Second Quarter 2016 Results
09 août 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency
04 août 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - August 04, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Announces First Quarter 2016 Results
10 mai 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 10, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein...
ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference
29 mars 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 29, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...